BALAXI PHARMACEUTICALS LIMITED — Others, 30-05-2025: Disclosure under SEBI Takeover Regulations

The company has announced a board meeting to review the financial results for the quarter and half-year. This update will shed light on recent operational performance and profitability, providing investors with clarity on growth trends. Outcomes from the meeting could impact the company’s strategic priorities and influence market perception, making it an important development for shareholders.